|
CN112220770A
|
|
Pharmaceutical composition of selepag and preparation method thereof
|
|
CN112225708A
|
|
Preparation method of mosapride intermediate
|
|
CN112022833A
|
|
Enzalutamide pharmaceutical composition and preparation method thereof
|
|
CN112057428A
|
|
Pharmaceutical composition of varenicline tartrate and preparation method thereof
|
|
CN111870583A
|
|
Espressol omeprazole sodium freeze-dried preparation for injection and preparation method thereof
|
|
CN111773189A
|
|
Azacitidine freeze-dried preparation for injection and preparation method thereof
|
|
CN111646958A
|
|
Preparation method of carfilzomib
|
|
WO2021023213A1
|
|
Salt and crystal form of steroid derivative regulator
|
|
WO2021018168A1
|
|
Anti-bcma antibody, antigen-binding fragment thereof and medical use thereof
|
|
CN112125975A
|
|
PD-L1 and CD47 bispecific fusion protein and medical application thereof
|
|
CN112079830A
|
|
Fused ring-containing derivative inhibitor, preparation method and application thereof
|
|
WO2020244657A1
|
|
Anti-b7-h4 antibody–drug conjugate and medicinal use thereof
|
|
WO2020239123A1
|
|
Aromatic heterocyclic derivative modulator and preparation method therefor and use thereof
|
|
WO2020239077A1
|
|
Nitrogen-containing heterocyclic derivative regulator, preparation method therefor and application thereof
|
|
CN112292378A
|
|
Indole derivative-containing inhibitor, preparation method and application thereof
|
|
WO2020228756A1
|
|
Inhibitor containing bicyclic derivative, preparation method therefor and use thereof
|
|
CN111925367A
|
|
Fused ring derivative inhibitor, preparation method and application thereof
|
|
CN111214450A
|
|
Empagliflozin tablet and preparation process thereof
|
|
CN111825758A
|
|
GLP-1 and GIP co-agonist compounds
|
|
WO2020211798A1
|
|
Inhibitor containing bicyclic ring derivative, and preparation method and uses therefor
|
